Bladder Cancer: From Diagnosis to Treatment
Painless blood in the urine is the most common first sign, and its stopping on its own does not mean the problem has gone. This page covers diagnosis, the muscle-invasion question and why follow-up lasts a lifetime.
Last medically reviewed: October 4, 2026 — Assoc. Prof. Dr. Müslüm Ergün
Private Online Consultation
A private, one-to-one video consultation by appointment, without visiting the clinic. Especially for patients who value privacy.
- Procedure time
- TURBT 30–60 minutes
- Anesthesia
- Spinal or general anaesthesia
- Hospital stay
- 1–2 nights for TURBT
- Stay in Türkiye
- 5–7 days (TURBT); considerably longer for cystectomy
- Return to work
- 1–2 weeks (TURBT)
- Flight clearance
- 7–10 days (TURBT)
About the condition
Bladder cancer arises from the cells lining the inner surface of the organ that stores urine. Its most common first sign is BLOOD IN THE URINE, and that bleeding is typically PAINLESS.
THE MOST IMPORTANT WARNING ON THIS PAGE IS THIS: if you have seen blood in your urine once and it had gone by the next day, the problem has not gone. In bladder cancer the bleeding comes and goes; the clear interval in between does not mean the disease is absent. The commonest mistake patients make is to put off seeking help because the bleeding stopped. Painless blood in the urine is a finding that must be investigated until proved otherwise.
THE MOST IMPORTANT RISK FACTOR IS SMOKING. The bladder is an organ in prolonged contact with substances excreted in urine; compounds from cigarette smoke are filtered by the kidneys and collect in the bladder. Long-term occupational exposure in the dye, rubber and certain chemical industries also carries risk.
The mainstay of diagnosis is cystoscopy: looking inside the bladder with a slim camera passed along the urinary passage. It is accompanied by imaging (usually CT urography) and urine cytology. Ultrasound alone is not sufficient; it can miss small tumours and flat, superficially spreading ones.
THE QUESTION THAT DETERMINES THE WHOLE OF TREATMENT IS THIS: has the tumour invaded the bladder muscle? In tumours that have not (superficial disease), the bladder is preserved and treatment is delivered inside it. Where the muscle is involved, removing the whole bladder comes into consideration. That distinction is made by pathological examination of the tissue taken at TURBT.
TURBT (removing the bladder tumour through the urinary passage) is both treatment and diagnosis: the tumour is removed and at the same time it becomes clear whether the muscle layer is involved. If the pathologist does not see muscle in the specimen, or if the tumour is high grade, a second TURBT may be needed 2–6 weeks later. That is not an error or a failure but a planned step.
Who is it suitable for?
May be suitable
- Any patient who has seen blood in the urine — it must be investigated even if painless and even if it stopped on its own
- Patients in whom a mass is found in the bladder at cystoscopy
- Patients with thickening of the bladder wall or a suspicious area on imaging
- Patients treated previously for a bladder tumour in whom a new lesion is found at follow-up
- Patients with a long smoking history or occupational exposure and unexplained urinary symptoms
May not be suitable
- Patients with an active urinary tract infection — infection also causes blood in the urine; it is treated first and the urine reassessed
- Patients with an uncontrolled bleeding disorder — this is corrected before the procedure
- Patients whose general condition is unsuited to radical surgery — bladder-preserving approaches and oncology collaboration then come into consideration
- Intensive treatment in older patients with a very limited life expectancy — the aim may be control of symptoms
Technology used
- Direct inspection of the bladder by cystoscopy
- CT urography — assessing the upper urinary tract as well
- Urine cytology
- TURBT (transurethral resection of bladder tumour) — sampling that includes the muscle layer
- Intravesical drug instillation (chemotherapy or BCG)
- Radical cystectomy and urinary reconstruction where required
Surgeon's experience
Verifiable information
- Surgeon's experience
- Assoc. Prof. Dr. Müslüm Ergün121270
Step-by-step journey
- Step 1
Investigating blood in the urine
Infection is excluded, urine cytology is taken, imaging is carried out and cystoscopy is planned. The bleeding having stopped does not halt the investigation.
- Step 2
TURBT
The tumour is removed through the urinary passage and a specimen including the muscle layer is taken. The procedure takes 30–60 minutes and usually requires 1–2 nights in hospital.
- Step 3
Pathology and risk group
The report states the grade of the tumour and whether it has invaded the muscle. Combined with the number and size of lesions, this determines the risk group, and the treatment plan follows from it.
- Step 4
If the muscle is not involved: treatment inside the bladder
In low risk, a single dose of intravesical chemotherapy may be enough. In intermediate and high risk, courses of intravesical BCG or chemotherapy are planned. In high-grade tumours a repeat TURBT comes into consideration.
- Step 4b
If the muscle is involved: radical treatment
Removing the whole bladder (radical cystectomy) with urinary reconstruction is considered. Chemotherapy before surgery comes into consideration for many patients. Bladder-preserving approaches are discussed in selected cases.
- Afterwards
Lifelong follow-up
Cystoscopy is carried out at set intervals. The intervals are determined by the risk group and lengthen over time, but they do not come to an end.
Method comparison
| Criterion | Non-muscle-invasive (superficial) | Muscle-invasive |
|---|---|---|
| Is the bladder preserved? | Yes | In most patients no |
| Main treatment | TURBT + intravesical drug | Radical cystectomy (often with chemotherapy) |
| Hospital stay | 1–2 nights | Considerably longer |
| How you pass urine | Unchanged | Permanently changed |
| Follow-up | Lifelong, by cystoscopy | Lifelong, by imaging and blood tests |
| How the decision is made | TURBT pathology | TURBT pathology + staging imaging |
This distinction determines the whole of treatment and can only be made by pathological examination. Imaging alone cannot establish muscle invasion with certainty.
Risks
- RECURRENCE: bladder cancer has a strong tendency to recur. The tumour having been removed does not mean the disease is over; that is the nature of the condition, not a failure of the method
- STOPPING FOLLOW-UP: this is the greatest real risk. A patient who feels well and does not come for cystoscopy can miss a recurrence that was still treatable
- Bleeding and burning on passing urine after TURBT — expected in the first days
- Perforation of the bladder — uncommon; it may require the catheter to stay in longer
- Urinary tract infection
- Narrowing of the urinary passage — can develop later
- Symptoms from intravesical BCG — frequency, burning, fever; rarely the treatment has to be stopped
- After radical cystectomy: a permanent change in how you pass urine, effects on sexual function, bowel problems and the risks of a long operation
Alternatives
- A single dose of intravesical chemotherapy after TURBT and surveillance, in low-risk tumours
- Courses of intravesical BCG or chemotherapy in intermediate to high risk
- Early radical cystectomy in high-risk disease that has not invaded the muscle — in selected patients
- Chemotherapy before surgery followed by radical cystectomy in muscle-invasive disease
- Bladder-preserving trimodal therapy (TURBT + radiotherapy + chemotherapy) — in selected patients
- Treatment aimed at controlling symptoms in patients unsuited to surgery
Recovery
First 48 hours (TURBT)
A catheter is in place and the bladder is irrigated if needed. Pink-to-red urine is an expected finding.
Week 1
The catheter has been removed. Burning and frequency may occur; plenty of fluids are advised. Heavy lifting is avoided.
Weeks 2–4
Daily life resumes. If intravesical treatment has been planned, it begins during this period.
Month 3 onwards
The first check cystoscopy is carried out. If it is clear, the intervals lengthen according to the risk group — but follow-up does not stop.
Frequently asked questions
I saw blood in my urine once and then it stopped. Should I still see a doctor?
Yes, without question. This is the most important message on this page. In bladder cancer the bleeding comes and goes; clear urine the next day does not mean the problem has passed. Painless blood in the urine is a finding to be investigated until proved otherwise. Waiting delays the diagnosis, and a delayed diagnosis makes treatment harder.
Is an ultrasound enough?
No. Ultrasound can show some masses but may miss small tumours and flat lesions spreading over the bladder surface. The basis of diagnosis is cystoscopy — looking directly inside the bladder.
The tumour has been removed — am I cured?
Removing the tumour is an important step but does not mean the disease is over. Bladder cancer has a strong tendency to recur. Follow-up by cystoscopy at set intervals is therefore required, and it lasts a lifetime. The intervals lengthen over time but do not come to an end.
Why is a second TURBT needed?
If no muscle was seen in the specimen taken at the first procedure, or if the tumour is high grade, a second resection is carried out 2–6 weeks later to be certain whether the disease has invaded the muscle. This is not an error but a planned step; incorrect staging leads to incorrect treatment.
Will my bladder be removed?
That only comes into consideration if the tumour has invaded the bladder muscle. In tumours that have not, the bladder is preserved and treatment is delivered inside it. The decision is made by pathological examination of the tissue taken at TURBT, not by imaging.
What is BCG treatment — is it chemotherapy?
No, BCG is an immune treatment; it is instilled into the bladder so that your own defences respond to the tumour cells. It can cause frequency, burning and fever. These effects are usually manageable, though rarely the treatment has to be stopped.
Does stopping smoking make any difference?
Yes. Smoking is the most important risk factor for bladder cancer, and stopping affects not only the risk of a new cancer but the course of the existing disease. It is the one step that contributes to treatment and is entirely in your own hands.
How long does follow-up last?
For life. The intervals are set by risk group and become less frequent over the years, but they are not abandoned. Feeling well is not a reason to stop; most recurrences are seen at cystoscopy before they cause any symptoms.
Can I have my follow-up at home after I return?
Yes, and that is in fact preferable. The pathology report, the risk group and the follow-up intervals are provided in writing so that your own urologist can schedule the cystoscopies. What matters is that the follow-up happens, not where.
Articles on this topic
Scientific sources
This page is for general information only and is not a substitute for medical advice.
Let's talk about this treatment
Message us on WhatsApp with your questions or fill in the pre-assessment form.
Pre-assessment form
Leave your details and our team will get back to you shortly.
Other treatments
Overactive Bladder and Urgency Incontinence
A sudden, hard-to-defer need to pass urine, going frequently, and sometimes not getting there in time. Treatment is stepwise, and most women improve markedly without needing medication or surgery.
Learn moreTesticular Cancer: Why Acting Early Changes Everything
The commonest solid cancer in young men, and one that responds very well to treatment. If you have noticed a painless lump, do not wait — delay turns a readily treatable disease into a harder one.
Learn moreStress Urinary Incontinence: the Treatment Options
Leaking urine when you cough, sneeze or exercise. The type has to be established first, and treatment should begin with the least invasive step — surgery is not the first option.
Learn more